Medical Oncology Division, Internal Medicine Department, PUCRS School of Medicine, Porto Alegre, Brazil
Breast Disease Division, Department of Gynecology and Obstetrics, Ribeirao Preto Medical School, University of Sao Paulo, Sao Paulo, Brazil
Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Hospital do Cancer Mae de Deus, Porto Alegre, Brazil
LACOG (Latin American Cooperative Oncology Group), Porto Alegre, Brazil
Copyright © 2017 Marcio Debiasi, Franklin Fernandes Pimentel, Paula Juliana Seadi Pereira, Carlos H. Barrios et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Debiasi, M. , Pimentel, F. , Pereira, P. and Barrios, C. (2017) Biosimilars in Brazil: The Beginning of an Era of Broader Access.
Journal of Cancer Therapy,
8, 814-826. doi:
10.4236/jct.2017.89071.